Status:
COMPLETED
A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis
Lead Sponsor:
Abbott
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to assess the long-term safety and clinical efficacy of adalimumab in patients with rheumatoid arthritis
Eligibility Criteria
Inclusion
- Completion of a previous D2E7 study
- Subject is in good health (Investigator discretion) with a recent stable medical history
Exclusion
- Former enrollment in this trial (DE018)
- Subject is considered by the investigator, for any reason, to be an unsuitable candidate for the study
- Female subject who is pregnant or breast feeding or considering becoming pregnant.
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
796 Patients enrolled
Trial Details
Trial ID
NCT00233571
Start Date
June 1 2000
End Date
June 1 2006
Last Update
November 22 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.